TGW - Transgender women
Jun 28, 2023 | Stories from the Field
It all started at a drag brunch. In May of 2021, ICAP’s Harlem Prevention Center (HPC) in New York City launched the I AM study, which aims to test the feasibility and impact of providing oral pre-exposure prophylaxis (PrEP) alongside gender-affirming hormone therapy...
Nov 23, 2022 | Stories from the Field
Pre-exposure prophylaxis – or PrEP – has proved to be a game-changer in helping reduce the transmission of HIV in countries around the world. As it continues to support the introduction of PrEP among vulnerable populations in regions where HIV is epidemic, ICAP at...
Dec 18, 2019 | In the Media, News
“To achieve HIV epidemic control, countries in Central Asia will need to address fundamental factors that drive HIV transmission and impede the engagement of people living with HIV and key populations, such as substance users, transgender and gay people, and...
Oct 25, 2018 | News
Representatives from the Eswatini Ministry of Health on October 25, 2018, officially launched a groundbreaking study of a new, long-acting, injectable drug for the prevention of HIV infection. This is the first investigational drug trial testing a new form of...
Oct 24, 2018 | In the Media, News
“HPTN 075 provides compelling findings that indicate an urgent need for further HIV prevention studies for men who have sex with men and transgender women in sub-Saharan Africa,” said Wafaa El-Sadr MD, MPH, MPA, HPTN co-principal investigator and professor...
